Old or new antihypertensive drugs?: Consequences from "ALLHAT"

被引：4

作者：

Düsing, R ^{[1
]}

机构：

[1] Med Univ Poliklin, D-53111 Bonn, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2003年 / 128卷 / 05期

关键词：

D O I：

10.1055/s-2003-36980

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：214 / 216

页数：3

共 12 条

[1] The verdict from ALLHAT - Thiazide diuretics are the preferred initial therapy for hypertension [J].

Appel, LJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (23) :3039-3042

[2]

Chalmers J, 1999, J HYPERTENS, V17, P151

[3] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

[4] Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: Further analyses from the antihypertensive and lipid-lowering treatment to prevent heart attack trial [J].

Davis, BR ;

Cutler, JA ;

Furberg, CD ;

Wright, JT ;

Farber, MA ;

Felicetta, JV ;

Stokes, JD .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (05) :313-320

[5]

Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967

[6]

Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981

[7] Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:: the Captopril Prevention Project (CAPPP) randomised trial [J].

Hansson, L ;

Lindholm, LH ;

Niskanen, L ;

Lanke, J ;

Hedner, T ;

Niklason, A ;

Luomanmäki, K ;

Dahlöf, B ;

de Faire, U ;

Mörlin, C ;

Karlberg, BE ;

Wester, PO ;

Björck, JE .

LANCET, 1999, 353 (9153) :611-616

[8] Randomised trial of old and new antihypertensive drugs in elderly patients:: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study [J].

Hansson, L ;

Lindholm, LH ;

Ekbom, T ;

Dahlöf, B ;

Lanke, J ;

Scherstén, B ;

Wester, PO ;

Hedner, T ;

de Faire, U .

LANCET, 1999, 354 (9192) :1751-1756

[9] Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy -: A Losartan Intervention For Endpoint Reduction (LIFE) substudy [J].

Kjeldsen, SE ;

Dahlöf, B ;

Devereux, RB ;

Julius, S ;

Aurup, P ;

Edelman, J ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristianson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Snapinn, S ;

Wedel, H .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (12) :1491-1498

[10] Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Lindholm, LH ;

Ibsen, H ;

Dahlöf, B ;

Devereux, RB ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Julius, S ;

Kjeldsen, SE ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H ;

Aurup, P ;

Edelman, J ;

Snapinn, S .

LANCET, 2002, 359 (9311) :1004-1010

← 1 2 →